Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01596140
Title Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center

Advanced Solid Tumor


Temsirolimus + Vemurafenib

Everolimus + Vemurafenib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST